Drug intelligence / Profile preview

indium in-111 pentetate

Development stage
Approved
Lead developer
GE Healthcare
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intrathecal
01

Overview

Indium In-111 pentetate is a radiopharmaceutical diagnostic agent composed of the radioactive isotope Indium In‑111 chelated with diethylenetriamine pentaacetic acid (DTPA). It is primarily used for radionuclide cisternography, a nuclear medicine imaging technique to evaluate cerebrospinal fluid (CSF) flow and detect abnormalities such as CSF leaks or blockages. After intrathecal administration, the compound travels with the CSF through the spinal canal and into cranial cisterns, allowing visualization via gamma camera due to photon emissions from Indium‑111 decay. The agent demonstrates efficient renal clearance and minimal background tissue accumulation, resulting in high-quality diagnostic images with low radiation exposure[1][2][3][5]. Its mechanism of action relies on its physical properties as a gamma-emitting tracer rather than pharmacological interaction with biological targets.

Brand names
Indium DTPA In 111IN-111 DTPAIN111 DTPAIN 111 DTPA
Other names
indium in 111 pentetateindium in 111 diethylenetriamine pentaacetatepentetate indium disodium in 111111in-dtpa

Beyond the preview

Go deeper on indium in-111 pentetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on indium in-111 pentetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call